Financial companies are leading the rush to file patents for tools and products based on blockchain, the ledger technology underlying bitcoin, and a wave of litigation could be on the horizon. Here is what intellectual property attorneys need to know about the patent landscape for the increasingly popular tech.
Japanese electronics maker Matsushita Electric Industrial Co. has sued Taiwanese chip maker MediaTek Inc in federal court in California for patent infringement related to integrated circuit chips.
Biotech companies Genentech, Inc. and Chiron have quietly settled the remaining patent disputes in a $300 million lawsuit over Genentech's metastatic breast cancer drug, Herceptin (Trastuzumab).
The U.S. Court of Appeals for the Federal Circuit has reluctantly agreed to launch a pilot program for voluntary mediation, a step that moves the court closer to joining the ranks of every other federal appeals court in the U.S.
Japanese electronics maker Toshiba Corp. has sued Korean chip maker Hynix Semiconductor Inc. in a California federal court, asking the court to declare that Toshiba isn’t infringing a patent for a method for making semiconductors.
Fresh from a bevy of settlements with several players in the futures market, software developer Trading Technologies is pressing on with a legal onslaught against another batch of competitors.
In a mixed decision, the U.S. Court of Appeals for the Federal Circuit has upheld some parts and struck down other parts of a ruling by a Virginia federal court in NTP Inc.’s closely watched patent lawsuit against Blackberry maker Research In Motion, Inc.
Swedish-U.K. drug maker AstraZeneca has sued India’s Ranbaxy Laboratories in New Jersey federal court over its plans to launch a generic version of ulcer and acid reflux drug Prilosec.
The U.S. Court of Appeals for the Federal Circuit has reinstated a $1.2 million verdict in favor of a maker of software to speed up online college applications.
Patent litigation is rising at a pace faster than all other federal disputes, prompting concerns about a growing threat of frivolous lawsuits and a flood of weak patents coming out of the U.S. Patent and Trademark Office.
The U.S. Patent and Trademark Office plans to launch a new reexamination office as part of an effort to improve decision-making quality and shave off excess time spent completing reviews, the agency said.
Electronics power management company O2Micro has sued Japanese electronics makers Sony Corp. and Rohm Co. Ltd. over a patent for liquid crystal display (LCD) television sets.
A company that has sued Eastman Kodak Co. for patent infringement of digital camera technology has withdrawn its complaint before the U.S. International Trade Commission to concentrate on a lawsuit in Delaware federal court.
A U.S. maker of anti-counterfeiting technology has sued the European Central Bank, claiming that every euro banknote in circulation infringes on a European patent.
A bill that would reform the U.S. patent system has stalled in Congress, with voting delayed until the end of the legislature’s annual August recess.
The Supreme Court of Canada has refused to consider the legality of an anti-piracy tax levied on digital music players, leaving a lower court’s ban on the tax intact.
A federal appeals court has stayed an injunction against medical device maker Medtronic, Inc. in a patent infringement lawsuit brought by musculoskeletal products company Biomet Inc. over polyaxial screws.
The U.S. International Trade Commission has agreed to investigate charges that Symbol Technologies violated U.S. trade practices by importing electronic devices that infringe patents held by Intermec Technologies Corp.
A federal judge in California has thrown out the last remaining claim in a patent infringement lawsuit brought by French software maker Business Objects SA against U.S. rival MicroStrategy Inc.
Teva Pharmaceutical Industries Ltd.’s $7.4 billion purchase of Ivax Corp. will once again propel the Israeli drug maker past Novartis as a leader in the $58-billion worldwide market for generic drugs. But the deal will force Teva to take a stand on the controversial practice of “authorized generics,” analysts say.
An appeal to the Supreme Court of a dispute between eBay and MercExchange over business methods raises fundamental questions about the use of injunctions during the appeals process in patent infringement cases, patent attorneys say.